Tumour necrosis factor antagonists: structure, function, and tuberculosis risks.
D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D012307:Risk Factors; D013329:Structure-Activity Relationship; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha